WOCKPHARMA2020-01-012020-03-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:FourOperatingExpenses02Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-01-012020-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2019-04-01 2020-03-31 2020-05-07 INR Crores Yearly Single segment Pharmaceuticals 2020-01-01 2020-03-31 Audited Consolidated 6869300000.00 137300000.00 7006600000.00 1803000000.00 1167200000.00 -183500000.00 1753400000.00 614400000.00 608700000.00 2194700000.00 7957900000.00 -951300000.00 0.00 -951300000.00 -247600000.00 -1191000000.00 -1438600000.00 0.00 487300000.00 304300000.00 106500000.00 197800000.00 0.00 685100000.00 614900000.00 1300000000.00 482900000.00 202200000.00 853600000.00 446400000.00 553700000.00 5 2.57 2.56 1.79 1.78 4.36 4.34 1. For Notes to Consolidated Results please refer the Notes from the Statement of Consolidated Audited Results for the quarter and year ended March 31 2020 as attached which is submitted under Outcome of Board Meeting today. n n2. Income represents Income from continuing operations , Expense represents Expenses from continuing operations and Tax expense represents Tax expense of continuing operations,Total profit before exceptional item and tax represents Profit / (Loss) before tax from Continuing Operations and profit before tax represents Profit / (Loss) before tax from Continuing Operations. n n3. Diluted EPS for year ended March 31, 2020 is Rs. -6.25 instead of Rs.- 6.29 . n n4. EPS for the Quarter ended March 31, 2020 from Continuing operations, Discontinued operations and Total EPS is not annualised. n nOCI Section: n5. Income tax relating items that will not be classified to Profit or loss includes income tax relating items that will not be classified to Profit or loss from Continuing operations and Discontinued operations. Single segment 2019-04-01 2020-03-31 Audited Consolidated 28439900000.00 388100000.00 28828000000.00 6217200000.00 5077000000.00 740300000.00 7433300000.00 2757400000.00 2241400000.00 7781800000.00 32248400000.00 -3420400000.00 0.00 -3420400000.00 -447300000.00 -1593600000.00 -2040900000.00 0.00 -1379500000.00 1453600000.00 508000000.00 945600000.00 0.00 -433900000.00 1008700000.00 574800000.00 -692200000.00 258300000.00 15200000.00 559600000.00 553700000.00 5 26163000000.00 -14.79 -14.79 8.54 8.50 -6.25 -6.29 Exchange Fluctuation Gain -74400000.00 Other Expenses 2269100000.00 Exchange Fluctuation Gain -212700000.00 Other Expenses 7994500000.00